We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Biotechnology's Bequest: New Drugs, Diagnostics

Beverly Merz
JAMA. 1987;258(11):1435. doi:10.1001/jama.1987.03400110015005.
Text Size: A A A
Published online


BIOTECHNOLOGY seems to defy easy definition. At least Joan Bennett, PhD, who chaired the recent Second Annual Conference on Biotechnology sponsored by the American Society for Microbiology in San Diego, thinks so.

Bennett, who is professor of biology at Tulane University, New Orleans, opened the conference by explaining how she had gleaned the writings of lexicographers and semanticists, hoping to find a well-turned phrase that captures the essence of the new discipline. She said that she had come away dissatisfied, and is still working on an economical description that links the diverse enterprises crowded under the umbrella of biotechnology.

Bennett's conundrum became easy to understand during the ensuing three days. Presentations on new agents ran the gamut from anti-idiotype antibodies to xerophobic bacteria and new applications ranged from agricultural to zoological. The presenters appeared to share only one characteristic—a propensity for tinkering with the innards of some type of microbe.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.